Advertisement
Home Tags Psoriasis

Tag: Psoriasis

Two experimental drugs

Two Experimental Drugs Promising for Psoriasis Rx

Targeted therapies produce significant results, researchers say
Regardless of severity

More Evidence Psoriasis and Depression Are Linked

But research doesn't prove one causes the other
Most patients with moderate to severe plaque psoriasis are prescribed medications

Study Looks at Costs for Moderate to Severe Plaque Psoriasis

Most patients prescribed one or more medications; six-month total direct costs per patient $11,291
Misconceptions of infection and contagion surround psoriasis

Misconceptions of Infection, Contagion Surround Psoriasis

Psoriasis is a highly stigmatizing condition; majority report feeling pity for those with psoriasis
Patients with psoriasis are at higher risk of developing arrhythmia

Psoriasis Patients at Higher Risk for Arrhythmia

Findings in patients with mild, severe disease and with/without psoriatic arthritis
The addition of kunzea oil does not improve the efficacy of topical psoriasis treatments containing liquor carbonis detergens and salicylic acid

Topical Kunzea Oil No Help for Psoriasis

No difference in efficacy with addition of kunzea oil to liquor carbonis detergens and salicylic acid
There is an increased risk of depression among women with psoriasis

Higher Risk for Depression With Psoriasis

Findings among women with psoriasis, psoriatic arthritis
Taking two 12-week courses of alefacept -- a drug already approved to treat psoriasis -- may help people with newly diagnosed type 1 diabetes mellitus preserve pancreatic β-cell function

Psoriasis Med May Help Preserve Pancreas Function in Type 1 DM

Used early after diagnosis, medication appears to have long-lasting effects
Preliminary trial results suggest that an experimental drug may be more efficacious for psoriasis than the current standard treatment. The results were published in the July 9 issue of the New England Journal of Medicine.

Experimental Drug Shows Promise in Treatment of Psoriasis

Guselkumab appears more effective than standard treatment, researchers report
Many newly diagnosed psoriatic arthritis patients have an increased risk of future cardiovascular disease

Risk of CVD Up in Newly Diagnosed Psoriatic Arthritis

Ten-year cumulative incidence of CVD events higher than predicted incidence based on FRS